| Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases PW Sperduto, N Kased, D Roberge, Z Xu, R Shanley, X Luo, PK Sneed, ... Journal of Clinical Oncology 30 (4), 419, 2012 | 1486 | 2012 |
| Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients PW Sperduto, ST Chao, PK Sneed, X Luo, J Suh, D Roberge, A Bhatt, ... International Journal of Radiation Oncology* Biology* Physics 77 (3), 655-661, 2010 | 1091 | 2010 |
| Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC· 3): a multicentre, randomised, controlled … PD Brown, KV Ballman, JH Cerhan, SK Anderson, XW Carrero, ... The Lancet Oncology 18 (8), 1049-1060, 2017 | 1072 | 2017 |
| Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial PD Brown, S Pugh, NN Laack, JS Wefel, D Khuntia, C Meyers, A Choucair, ... Neuro-oncology 15 (10), 1429-1437, 2013 | 920 | 2013 |
| Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG oncology CC001 PD Brown, V Gondi, S Pugh, WA Tome, JS Wefel, TS Armstrong, JA Bovi, ... Journal of Clinical Oncology 38 (10), 1019-1029, 2020 | 635 | 2020 |
| Estimating survival in patients with lung cancer and brain metastases: an update of the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA) PW Sperduto, TJ Yang, K Beal, H Pan, PD Brown, A Bangdiwala, ... JAMA oncology 3 (6), 827-831, 2017 | 634 | 2017 |
| Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases PW Sperduto, N Kased, D Roberge, Z Xu, R Shanley, X Luo, PK Sneed, ... International Journal of Radiation Oncology* Biology* Physics 82 (5), 2111-2117, 2012 | 413 | 2012 |
| A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment ME Robson, PO Chappuis, J Satagopan, N Wong, J Boyd, JR Goffin, ... Breast Cancer Research 6, 1-10, 2003 | 355 | 2003 |
| Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient PW Sperduto, S Mesko, J Li, D Cagney, A Aizer, NU Lin, E Nesbit, ... Journal of clinical oncology 38 (32), 3773, 2020 | 294 | 2020 |
| The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy A Sahgal, D Roberge, D Schellenberg, TG Purdie, A Swaminath, ... Clinical oncology 24 (9), 629-639, 2012 | 264 | 2012 |
| Estimating survival in melanoma patients with brain metastases: an update of the graded prognostic assessment for melanoma using molecular markers (Melanoma-molGPA) PW Sperduto, W Jiang, PD Brown, S Braunstein, P Sneed, DA Wattson, ... International Journal of Radiation Oncology* Biology* Physics 99 (4), 812-816, 2017 | 193 | 2017 |
| Principles and practice of stereotactic radiosurgery LS Chin, WF Regine Springer Science & Business Media, 2010 | 189 | 2010 |
| The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer PW Sperduto, N Kased, D Roberge, ST Chao, R Shanley, X Luo, ... Journal of neuro-oncology 112, 467-472, 2013 | 185 | 2013 |
| Adult cerebellar medulloblastomas: the pathological, radiographic, and clinical disease spectrum JL Hubbard, BW Scheithauer, DB Kispert, SM Carpenter, MR Wick, ... Journal of neurosurgery 70 (4), 536-544, 1989 | 180 | 1989 |
| Inhibition of the G2 DNA damage checkpoint and of protein kinases Chk1 and Chk2 by the marine sponge alkaloid debromohymenialdisine D Curman, B Cinel, DE Williams, N Rundle, WD Block, AA Goodarzi, ... Journal of Biological Chemistry 276 (21), 17914-17919, 2001 | 165 | 2001 |
| Radiological and pathological response following pre-operative radiotherapy for soft-tissue sarcoma D Roberge, T Skamene, A Nahal, RE Turcotte, T Powell, C Freeman Radiotherapy and oncology 97 (3), 404-407, 2010 | 147 | 2010 |
| Intensity-modulated radiotherapy for craniospinal irradiation: target volume considerations, dose constraints, and competing risks W Parker, E Filion, D Roberge, CR Freeman International Journal of Radiation Oncology* Biology* Physics 69 (1), 251-257, 2007 | 136 | 2007 |
| Treatment guidelines for preoperative radiation therapy for retroperitoneal sarcoma: preliminary consensus of an international expert panel EH Baldini, D Wang, RLM Haas, CN Catton, DJ Indelicato, DG Kirsch, ... International Journal of Radiation Oncology* Biology* Physics 92 (3), 602-612, 2015 | 122 | 2015 |
| FDG PET/CT in initial staging of adult soft‐tissue sarcoma D Roberge, S Vakilian, YZ Alabed, RE Turcotte, CR Freeman, M Hickeson Sarcoma 2012 (1), 960194, 2012 | 112 | 2012 |
| Beyond an updated graded prognostic assessment (breast GPA): a prognostic index and trends in treatment and survival in breast cancer brain metastases from 1985 to today PW Sperduto, S Mesko, J Li, D Cagney, A Aizer, NU Lin, E Nesbit, ... International Journal of Radiation Oncology* Biology* Physics 107 (2), 334-343, 2020 | 104 | 2020 |
